Comparative statistics by cancer registry
Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
(Izmir, Turkey, 1995-1997 cases followed-up until 2003)Click on cancer site (ICD-10 code) for comparison
Site | ICD-10 | No. of cases | Male | Female | Number of cases by age group | Relative survival by age group | ||||||||||||
5-year survival | 5-year survival | |||||||||||||||||
No. | Abs | Rel | No. | Abs | Rel | <45 | 45-54 | 55-64 | 65-74 | 75+ | <45 | 45-54 | 55-64 | 65-74 | 75+ | |||
C18 | Colon | 371 | 217 | 42.8 | 50.1 | 154 | 48.0 | 56.1 | 49 | 60 | 97 | 120 | 45 | 48.0 | 57.8 | 51.8 | 51.4 | 55.6 |
C19-20 | Rectum | 344 | 192 | 47.8 | 55.9 | 152 | 39.6 | 43.8 | 64 | 66 | 85 | 99 | 30 | 39.4 | 48.3 | 47.7 | 64.5 | 53.0 |
C32 | Larynx | 478 | 450 | 61.9 | 70.8 | 28 | 66.2 | 73.2 | 55 | 118 | 164 | 121 | 20 | 72.7 | 68.9 | 72.9 | 71.3 | 58.4 |
C50 | Breast | 1329 | 36 | 66.5 | 76.4 | 1293 | 71.2 | 76.7 | 387 | 360 | 310 | 211 | 61 | 73.1 | 75.2 | 80.4 | 82.5 | 72.2 |
C53 | Cervix | 246 | 246 | 58.8 | 62.3 | 66 | 71 | 66 | 39 | 4 | 70.9 | 63.3 | 60.0 | 54.4 | 0.0 | |||
C56 | Ovary | 230 | 230 | 54.7 | 59.0 | 58 | 47 | 66 | 48 | 11 | 66.9 | 64.2 | 49.5 | 57.1 | 64.6 | |||
C67 | Urinary bladder | 566 | 508 | 57.5 | 69.4 | 58 | 59.2 | 72.0 | 35 | 85 | 168 | 197 | 81 | 84.7 | 73.3 | 66.6 | 68.1 | 67.0 |
C81 | Hodgkin lymphoma | 85 | 56 | 65.1 | 68.4 | 29 | 66.4 | 68.8 | 58 | 11 | 9 | 5 | 2 | 72.5 | 53.7 | 62.8 | 32.7 | 138.2 |
C82-85+C96 | Non-Hodgkin lymphoma | 344 | 194 | 40.3 | 43.9 | 150 | 51.4 | 56.7 | 117 | 55 | 82 | 72 | 18 | 54.1 | 50.5 | 49.4 | 41.0 | 42.2 |
C90 | Multiple myeloma | 79 | 41 | 26.0 | 30.4 | 38 | 31.5 | 34.6 | 9 | 22 | 25 | 20 | 3 | 14.0 | 39.7 | 34.4 | 27.3 | 54.3 |
C91 | Lymphoid leukaemia | 161 | 93 | 45.8 | 49.6 | 68 | 51.3 | 53.8 | 96 | 20 | 16 | 19 | 10 | 53.4 | 47.1 | 49.8 | 37.7 | 73.7 |
C92-94 | Myeloid leukaemia | 148 | 78 | 23.4 | 26.2 | 70 | 38.0 | 40.4 | 60 | 20 | 22 | 32 | 14 | 38.7 | 37.4 | 22.3 | 23.2 | 25.3 |
Graphs:
Other tables available for this registry:
- Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
- Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
- Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
- Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
- Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Izmir, Turkey, 1995-1997) |
Registry chapter:
Consult the chapter in Cancer survival in developping countries (Volume II) |